Published in
American Association for the Advancement of Science, Science Immunology, 44(5), 2020
DOI: 10.1126/sciimmunol.aaz3199
Links
Tools
Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes
Journal article published in 2020 by
Tianshi Lu 
,
Shidan Wang ,
Lin Xu,
Qinbo Zhou,
Nirmish Singla,
Jianjun Gao ,
Subrata Manna,
Laurentiu Pop ,
Zhiqun Xie ,
Mingyi Chen ,
Jason J. Luke ,
James Brugarolas,
Raquibul Hannan ,
Tao Wang
,
Shidan Wang ,
Lin Xu,
Qinbo Zhou,
Nirmish Singla,
Jianjun Gao ,
Subrata Manna,
Laurentiu Pop ,
Zhiqun Xie ,
Mingyi Chen ,
Jason J. Luke ,
James Brugarolas,
Raquibul Hannan ,
Tao Wang
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
CSiN score is an improved tool to assess the overall quality of tumor neoantigens that predicts response to immunotherapy.